Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Findings in rats warrant no clinical volume management changes; leaves open central AT2-NO pathways in sympatho-inhibition for targeted study.
Abdulla et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: